Marker Therapeutics, Inc. — Director's Dealing 2016

Dec 14, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TAPIMMUNE INC (TPIV)
CIK: 0001094038
Period of Report: 2016-12-12

Reporting Person: BONFIGLIO JOHN N (Director, President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-12	Common Stock	M	10417	$1.74	Acquired	31251	Direct
2016-12-12	Common Stock	G	10417	—	Disposed	20834	Direct
2016-12-12	Common Stock	G	10417	—	Acquired	10417	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-12	Employee Stock Option (Right to Buy)	$1.74	M	10417	Disposed	2025-02-10	Common Stock (10417)	Direct

Footnotes

F1: Represents a partial exercise of a stock option award under the Company's 2014 Omnibus Stock Ownership Plan (the "Plan") originally granted in connection with services to the Company as a consultant. The options fully vested on January 31, 2016. In connection with the exercise of the options, Reporting Person transferred the shares to his spouse.